Chemoinformaics analysis of gamma-l-glutamyl-s-allyl-l-cysteine
Molecular Weight | 306.34 | nRot | 10 |
Heavy Atom Molecular Weight | 288.196 | nRig | 4 |
Exact Molecular Weight | 306.089 | nRing | 0 |
Solubility: LogS | -1.323 | nHRing | 0 |
Solubility: LogP | -3.544 | No. of Aliphatic Rings | 0 |
Acid Count | 2 | No. of Aromatic Rings | 0 |
Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 38 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 0 |
nHetero | 9 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 2 | No. of Arom Atom | 0 |
No. of Oxygen atom | 6 | No. of Arom Bond | 0 |
nHA | 5 | APOL | 40.2843 |
nHD | 4 | BPOL | 25.2197 |
QED | 0.288 |
Synth | 4.346 |
Natural Product Likeliness | 0.475 |
NR-PPAR-gamma | 0.033 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0 |
Pgp-sub | 0.357 |
HIA | 0.023 |
CACO-2 | -6.337 |
MDCK | 0.000569415 |
BBB | 0.164 |
PPB | 0.2568 |
VDSS | 0.293 |
FU | 0.6313 |
CYP1A2-inh | 0 |
CYP1A2-sub | 0.021 |
CYP2c19-inh | 0.027 |
CYP2c19-sub | 0.037 |
CYP2c9-inh | 0.131 |
CYP2c9-sub | 0.67 |
CYP2d6-inh | 0.009 |
CYP2d6-sub | 0.124 |
CYP3a4-inh | 0.007 |
CYP3a4-sub | 0.002 |
CL | 2.307 |
T12 | 0.829 |
hERG | 0.01 |
Ames | 0.047 |
ROA | 0.02 |
SkinSen | 0.131 |
Carcinogencity | 0.095 |
EI | 0.054 |
Respiratory | 0.382 |
NR-Aromatase | 0.003 |
Antiviral | Yes |
Prediction | 0.637551 |